[Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 2. The importance of anamnestic and diagnostic characteristics for successful therapy].
D000328:Adult; D000367:Age Factors; D000368:Aged; D000704:Analysis of Variance; D000787:Angina Pectoris / Q000150:complications; D001381:Azepines / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D004562:Electrocardiography; D004812:Epidemiologic Methods; D005069:Evaluation Studies as Topic; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D009574:Nitro Compounds / Q000627:therapeutic use; D012737:Sex Factors; D013223:Statistics as Topic; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
D001381:Azepines; D001565:Benzoates; D009574:Nitro Compounds; D014665:Vasodilator Agents
Statistische Auswertung einer Gemeinschaftsstudie zur Untersuchung der Wirksamkeit des Koronartrainers Dilazep bei ischämischen Herzerkrankungen. 2. Mitteilung: Bedutung anamnestischer und diagnostischer Merkmale für den Therapieerfolg